Hundreds of biotech leaders are pledging to stop working with Russian companies and to reject investment from Russian funds in response to the country’s invasion …
Final study results show Pfizer’s experimental COVID-19 pill remained as effective as indicated by preliminary data last month, a major relief after promising data for …
Lilly’s deal with Regor is another example of large pharmaceutical companies in the U.S. and Europe showing interest in Chinese biotechs for their research, rather …
Shkreli became a symbol of pharmaceutical greed after his company, formerly Turing Pharmaceuticals, bought Daraprim in 2015 and then raised the price to $750 a …
Neurocrine is perhaps best known for its work in movement disorders and women’s health, having developed approved medications for tardive dyskinesia and the pain associated …
Livtencity is part of the first wave of new products Takeda hopes will reposition the company as a top player in the pharmaceutical industry for …
Mammoth’s evolution into a drugmaker appears to be paying off. Three years ago, the company formed with a plan to use CRISPR gene editing to …
In some ways, AstraZeneca’s COVID-19 response has been as good as any in the biopharmaceutical industry. The British drugmaker licensed and developed an effective COVID-19 …
Merck’s filing comes less than two weeks after the drugmaker showed molnupiravir lowered the risk of hospitalization or death by roughly 50% in a Phase …
Voyager’s first generation of gene therapies for ALS, Parkinson’s and Huntington’s disease, all now discontinued, relied on a direct infusion into brain tissue, an invasive …
The announcement from Moderna comes amid criticism of the drugmaker, and other Western companies with authorized coronavirus vaccines, for not doing more to share their …
Insurers Centene and Humana have sued Merck & Co., alleging the drugmaker’s “monopolistic scheme” delayed generic versions of its blockbuster cholesterol drug Zetia from coming …
Before J&J become one of three companies that earned Food and Drug Administration approval for a coronavirus vaccine, the pharma was already a leader in …
